Blunted growth hormone response to clonidine in post-traumatic stress disorder

Psychoneuroendocrinology

Volumn 29, Issue 2, 2004, Pages 269-278

  Morris, Philip ^a,c   Hopwood, Malcolm ^b   Maguire, Kay ^b   Norman, Trevor ^b   Schweitzer, Isaac ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NONE   (Australia)

Author keywords

Clonidine; Depression; Growth hormone; Neuroendocrine; Noradrenaline; Post traumatic stress disorder

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; GROWTH HORMONE;

ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; GROWTH HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; NORADRENERGIC SYSTEM; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SOLDIER; VIET NAM; WAR;

EID: 0242289455     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00027-1     Document Type: Article

References (35)

1. Aardal-Eriksson E., Eriksson T.E., Holm A.C., Lundin T. Salivary cortisol and serum prolactin in relation to stress rating scales in a group of rescue workers. Biol. Psychiatry. 46:1999;850-855.
2. Diagnostic and Statistical Manual of Mental Disorders. third ed. revised :1987;American Psychiatric Association, Washington, DC.
3. Blanchard E.B., Kolb L.C., Prins A., Gates S., McCoy G.C. Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with post traumatic stress disorder. J. Nerv. Ment. Dis. 179:1991;371-373.
4. Bremner J.D., Innis R.B., Ng C.K., Staib L.H., Salomon R.M., Bronen R.A., Duncan J., Southwick S.M., Krystal J.H., Rich D., Zubal G., Dey H., Soufer R., Charney D.S. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related post-traumatic stress disorder. Arch. Gen. Psychiatry. 54:1997;246-254.
5. Castro R.C., Vieira J.G., Besser G.M., Grossman A.B., Lengyel A.M. Pyridostigmine enhances but does not normalise the GH response to GH-releasing hormone in obese subjects. Acta Endocrinol. 122:1990;385-390.
6. Charney D.S., Heninger G.R., Strenberg D.E., Hafstad K.M., Giddings S., Landis H. Adrenergic receptor sensitivity in depression. Arch. Gen. Psychiatry. 39:1982;290-294.
7. Davidson J., Smith R., Kudler H. Validity and reliability of the DSM-III criteria for post-traumatic stress disorder - experience with a structured interview. J. Nerv. Ment. Dis. 177:1989;336-346.
8. Dinan T.G., Barry S., Yatham L.N., Mobayed M., Brown I. A pilot study of a neuroendocrine test battery in post-traumatic stress disorder. Biol. Psychiatry. 28:1990;665-672.
9. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 12:1975;189-198.
10. 2O PET study of the neuromodulatory effects of clonidine. Biol. Psychiatry. 49:2001;317-325.
11. Geracioti T.D., Baker D.G., Ekhator N.N., West S.A. CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry. 158:2001;1227-1230.
12. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50.
13. Hamilton M. A rating scale for depression. J. Neurol.-Neurosurg. Psychiatry. 23:1960;56-62.
14. Hansenne M., Pitchot W., Ansseau M. The clonidine test in posttraumatic stress disorder. Am. J. Psychiatry. 148:1991;810-811.
15. Horowitz M., Wilner N., Alvarez W. Impact of events scale: a measure of subjective distress. Psychosom. Med. 41:1979;209-218.
16. Keane T.M., Fairbank J.A., Caddell J.M., Zimmering R.T., Taylor K.L., Mora C.A. Clinical evaluation of a measure to assess combat exposure. Psychol. Assess. 1:1989;53-55.
17. Kosten T.R., Mason J.W., Giller E.L., Ostroff R.B., Harkness L. Sustained urinary norepinephrine and epinephrine elevation in post traumatic stress disorder. Psychoneuroendocrinology. 12:1987;3-20.
18. Matussek N., Ackenheil M., Hippius H., Muller F., Schroeder H.T., Schultes H., Wasilewski B. Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res. 2:1980;25-36.
19. McFall M.E., Murburg M.M., Ko G.N., Veith R.C. Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol. Psychiatry. 27:1990;1165-1175.
20. Mellman T.A., Kumar A., Kulick-Bell R., Kumar M., Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol. Psychiatry. 38:1995;174-179.
21. Mokrani M.C., Duval F., Diep T.S., Bailey P.E., Macher J.P. Multihormonal response to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology. 25:2000;741-752.
22. Neal L.A., Busuttil W., Rollins J., Herepath R., Strike P., Turnbull G. Convergent validity of measures of post-traumatic stress disorder in a mixed military civilian population. J. Traumatic Stress. 7:1994;447-455.
23. 2-adrenergic binding sites in post-traumatic stress disorder. Am. J. Psychiatry. 144:1987;1511-1512.
24. Pitman R., Orr S. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related post-traumatic stress disorder. Biol. Psychiatry. 27:1990;245-247.
25. Rasmussen A.M., Hauger R.L., Morgan C.A., Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide Y levels in combat-related PTSD. Biol. Psychiatry. 47:2000;526-539.
26. Schittecatte M., Charles G., Machowski R., Dumont F., Garcia-Valentin J., Wilmotte J., Papart P., Pitchot W., Wauthy J., Ansseau M., Hoffman G., Pelc I. Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicentre study. Am. J. Psychiatry. 151:1994;216-220.
27. Siever L.J., Davis K.L. Overview: toward a dysregulation hypothesis of depression. Am. J. Psychiatry. 142:1985;1017-1031.
28. Southwick S.M., Krystal J.H., Morgan C.A., Johnson D.R., Nagy L.M., Nicolaou A., Heninger G.R., Charney D.S. Abnormal noradrenergic function in post-traumatic stress disorder. Arch. Gen. Psychiatry. 50:1993;266-274.
29. Southwick S.M., Krystal J.H., Bremner J.D., Morgan C.A., Nicolaou A., Nagy L.M., Johnson D.R., Heninger G.R., Charney D.S. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry. 54:1997;749-758.
30. Southwick S.M., Bremner J.D., Rasmussen A., Morgan C.A., Arnsten A., Charney D.S. Norepinephrine: new vistas for an old neurotransmitter. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiatry. 46:1999;1192-1204.
31. Composite International Diagnostic Interview. 1987;WHO, Geneva, Switzerland.
32. Yatham L.N., Sacamano J., Kusumakoar V. Assessment of noradrenergic functioning in patients with non-combat-related post-traumatic stress disorder: a study with desmethylimipramine and orthostatic challenge. Psychiatry Res. 63:1996;1-6.
33. Yehuda R., Southwick S., Giller E.L., Xiaowan M.A., Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J. Nerv. Ment. Dis. 180:1992;321-325.
34. Yehuda R., Southwick S.M., Krystal J.H., Bremner D., Vharney D.S., Mason A.W. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry. 150:1993;83-86.
35. Yehuda R., Siever L.J., Teicher M.H., Levengood R.A., Gerber D.K., Schmeidler J., Yang R.K. Plasma norepinephrine and 3-methoxy-4- hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol. Psychiatry. 44:1998;56-63.